Hunan Zhongsheng peptide biotechnology Co., Ltd. initiates listing guidance.
According to the official website of the China Securities Regulatory Commission (CSRC), Hunan Zhongsheng Fullpeptide Biotechnology Co., Ltd. officially began the listing counseling on March 13, 2026. Shenzhen Wanxianghuiyuan Securities Underwriting Sponsorship Co., Ltd. served as the counseling institution.
Latest

